Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accendra Health (ACH) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to -$172.5 million.

  • Accendra Health's Cash from Operations fell 73177.94% to -$172.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$99.0 million, marking a year-over-year decrease of 14893.48%. This contributed to the annual value of $161.5 million for FY2024, which is 7819.73% down from last year.
  • According to the latest figures from Q3 2025, Accendra Health's Cash from Operations is -$172.5 million, which was down 73177.94% from $37.6 million recorded in Q2 2025.
  • Accendra Health's Cash from Operations' 5-year high stood at $313.1 million during Q2 2023, with a 5-year trough of -$172.5 million in Q3 2025.
  • Moreover, its 5-year median value for Cash from Operations was $68.5 million (2022), whereas its average is $62.2 million.
  • In the last 5 years, Accendra Health's Cash from Operations soared by 79005.92% in 2022 and then crashed by 73177.94% in 2025.
  • Quarter analysis of 5 years shows Accendra Health's Cash from Operations stood at $50.3 million in 2021, then skyrocketed by 72.74% to $87.0 million in 2022, then increased by 28.52% to $111.8 million in 2023, then tumbled by 36.47% to $71.0 million in 2024, then tumbled by 342.98% to -$172.5 million in 2025.
  • Its Cash from Operations stands at -$172.5 million for Q3 2025, versus $37.6 million for Q2 2025 and -$35.1 million for Q1 2025.